Mark A. Velleca, President and CEO at G1 Therapeutics, Inc. (GTHX), sold 7,500 shares at $46.17 ($347K) on 2018-05-15, disclosed to the SEC on 2018-05-16.
Open-market sale of $347k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.17 | 5,800 | $268K | 77.2% |
| 2 | $46.63 | 1,700 | $79K | 22.8% |
| Total | $46.27 avg | 7,500 | $347K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |